EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disulfide Cross-Linked Thiolated Chitosan/Oxidized Dextran–Oleylamine Micelle–Hydrogel System with pH/ROS Dual-Responsive Cascade Drug Release for Integrated Colon Targeting and Mucosal Repair in Inflammatory Bowel Disease

Jiangtao He, Chunyu Gan, Tongxia Chi, Jia Liu, Tuya Bai, Xin Wu, Guodong Liang iD, Ruijuan Li iD, Yuheng Ma iD

Pharmaceutics · 14.05.2026 · 18 (5) · 602

DOI: 10.3390/pharmaceutics18050602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 14.05.2026. Verfasst von Jiangtao He und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Natural and Biomimetic Drugs, the Natural Science Foundation of Inner Mongolia Autonomous Region, Education Department of Inner Mongolia Autonomous Region "Higher School Research Program".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral colon-targeted delivery for inflammatory bowel disease (IBD) faces significant challenges, including limited gastrointestinal stability, premature drug release, and insufficient mucosal retention.

Methods

To address these limitations, a mucoadhesive polysaccharide-based composite hydrogel incorporating prednisolone-loaded polymeric micelles was developed to enhance colonic delivery and promote mucosal repair. Amphiphilic oxidized dextran–oleylamine (ODEX-OA) copolymers were synthesized to self-assemble into prednisolone-loaded micelles. These micelles were subsequently embedded within a thiolated chitosan (CSSH) hydrogel through a Schiff base reaction, yielding the ODEX-OA-Pred-CSSH composite. The resulting system was comprehensively characterized for particle size, mucoadhesion, degradation, and pH/ROS dual-responsive drug release. Its colon-targeting capability and therapeutic efficacy were subsequently assessed in a dextran sulfate sodium (DSS)-induced colitis mouse model.

Results

In vitro, the composite hydrogel demonstrated nanoscale micellar size, enhanced drug release kinetics under simulated inflammatory colonic conditions, and prolonged colonic retention for up to 24 h following oral administration. In vivo, studies confirmed that ODEX-OA-Pred-CSSH significantly alleviated colitis, evidenced by a reduced disease activity index, diminished pro-inflammatory cytokine levels, restored colon length, decreased spleen index, and improved histological mucosal repair.

Conclusions

These findings collectively suggest that this mucoadhesive micelle–hydrogel composite represents a promising and effective oral colon-targeted platform for the treatment of IBD.

Schlagwörter

Stichwörter der Autor:innen

inflammatory bowel diseasemucoadhesive hydrogelmucosal repairoral colon-targeted deliverypolymeric micelles

Autor:innen und Institutionen

  • College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China.
  • Inner Mongolia Autonomous Region Engineering Research Center of New Pharmaceutical Screening, Inner Mongolia Medical University, Hohhot 010110, China.
  • Shanghai Wei Er Lab, No. 358, Tian Chen Road, Qingpu District, Shanghai 201707, China.

ORCID-Profile: Guodong Liang, Ruijuan Li, Yuheng Ma

Förderung

  • State Key Laboratory of Natural and Biomimetic Drugs
  • the Natural Science Foundation of Inner Mongolia Autonomous Region
  • Education Department of Inner Mongolia Autonomous Region "Higher School Research Program"
  • National Natural Science Foundation of China
  • ducation Department of Inner Mongolia Autonomous Region "Young Science and Technology Talent Support Program
  • University-level Project of Inner Mongolia Medical University
  • Education Department of Inner Mongolia Autonomous Region “Higher School Research Program”
  • Education Department of Inner Mongolia Autonomous Region “Young Science and Technology Talent Support Program”

Zitieren

APA

He, J., Gan, C., Chi, T., Liu, J., Bai, T., Wu, X., Liang, G., Li, R., & Ma, Y. (2026). Disulfide Cross-Linked Thiolated Chitosan/Oxidized Dextran–Oleylamine Micelle–Hydrogel System with pH/ROS Dual-Responsive Cascade Drug Release for Integrated Colon Targeting and Mucosal Repair in Inflammatory Bowel Disease. Pharmaceutics, 18(5), 602. https://doi.org/10.3390/pharmaceutics18050602

Vancouver

He J, Gan C, Chi T, Liu J, Bai T, Wu X, et al. Disulfide Cross-Linked Thiolated Chitosan/Oxidized Dextran–Oleylamine Micelle–Hydrogel System with pH/ROS Dual-Responsive Cascade Drug Release for Integrated Colon Targeting and Mucosal Repair in Inflammatory Bowel Disease. Pharmaceutics. 2026;18(5):602. doi:10.3390/pharmaceutics18050602

BibTeX
@article{He2026,
  author = {He, Jiangtao and Gan, Chunyu and Chi, Tongxia and Liu, Jia and Bai, Tuya and Wu, Xin and Liang, Guodong and Li, Ruijuan and Ma, Yuheng},
  title = {Disulfide Cross-Linked Thiolated Chitosan/Oxidized Dextran–Oleylamine Micelle–Hydrogel System with pH/ROS Dual-Responsive Cascade Drug Release for Integrated Colon Targeting and Mucosal Repair in Inflammatory Bowel Disease},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {602},
  doi = {10.3390/pharmaceutics18050602}
}
Kostenlos starten →